Your body manufactures it automatically to prevent overeating and maintain metabolic balancebut some people genetically produce less, contributing to weight gain and hunger dysregulation
That said, Germany remains deeply engaged with GLP-1 research, accounting for 12.4% of all global GLP-1 clinical trial activity in 2025, according to GlobalDatas trials database
TECs, key components of the kidney, are vulnerable to physical and chemical damage, including hypoxia, toxins, proteinuria, metabolic diseases, and senescence [4]
[15] The SmPCs for weight management products (Wegovy, Saxenda) recommend monitoring for depression or suicidal thoughts and discontinuing treatment if these occur
The conversation has spent too much time debating the medication and not enough time discussing the model surrounding it
It can also suit those who want to understand how their body responds to GLP-1 treatment before committing to an ongoing prescription, or individuals who have a credible plan for maintaining progress after stopping and are looking for help with initial momentum